These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39029387)

  • 1. Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the Head and Neck Cancer Registry of Japan.
    Ichisaka T; Sano D; Kijima N; Kawakita D; Yoshimoto S; Kitayama M; Nibu KI; Oridate N
    Oral Oncol; 2024 Oct; 157():106942. PubMed ID: 39029387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter to the editor, "Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the head and neck Cancer Registry of Japan.".
    Jeyaraj G
    Oral Oncol; 2024 Oct; 157():106974. PubMed ID: 39053286
    [No Abstract]   [Full Text] [Related]  

  • 3. WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer.
    Tiefenböck-Hansson K; Haapaniemi A; Farnebo L; Palmgren B; Tarkkanen J; Farnebo M; Munck-Wikland E; Mäkitie A; Garvin S; Roberg K
    Oncol Rep; 2017 Oct; 38(4):2062-2068. PubMed ID: 28849066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of S-1 to radiotherapy for treatment of T2N0 glottic cancer: Results of the multiple-center retrospective cohort study in Japan with a propensity score analysis.
    Sano D; Tanabe T; Kubota A; Miyamoto S; Tanigaki Y; Okami K; Komatsu M; Ikoma R; Suzuki K; Akazawa Y; Kobayashi S; Yamada Y; Oridate N
    Oral Oncol; 2019 Dec; 99():104454. PubMed ID: 31675682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma.
    Beyaert S; Hamoir M; Van Maanen A; Grégoire V; Schmitz S
    Eur J Surg Oncol; 2019 Jul; 45(7):1188-1195. PubMed ID: 30940421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent hyperfractionated radiotherapy and carboplatin with transoral debulking microsurgery for T2N0 glottic cancer.
    Ohguri T; Imada H; Nakano K; Yahara K; Udaka T; Suzuki H; Korogi Y
    Head Neck; 2008 Aug; 30(8):1027-34. PubMed ID: 18302271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
    Hitt R; Iglesias L; López-Pousa A; Berrocal-Jaime A; Grau JJ; García-Girón C; Martínez-Trufero J; Guix M; Lambea-Sorrosal J; Del Barco-Morillo E; León-Vintró X; Cunquero-Tomas AJ; Baste N; Ocaña A; Cruz-Hernández JJ;
    Clin Transl Oncol; 2021 Apr; 23(4):764-772. PubMed ID: 32797376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer.
    Chung SY; Kim KH; Keum KC; Koh YW; Kim SH; Choi EC; Lee CG
    Cancer Res Treat; 2018 Jan; 50(1):156-163. PubMed ID: 28301924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group.
    Lyhne NM; Johansen J; Kristensen CA; Andersen E; Primdahl H; Andersen LJ; Oksbjerg S; Overgaard J
    Eur J Cancer; 2016 May; 59():46-56. PubMed ID: 27014799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.
    Chera BS; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):461-6. PubMed ID: 20153124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control.
    Akimoto T; Nonaka T; Kitamoto Y; Ishikawa H; Ninomiya H; Chikamatsu K; Furuya N; Hayakawa K; Mitsuhashi N; Nakano T
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):995-1001. PubMed ID: 16406396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
    Nonoshita T; Shioyama Y; Kunitake N; Nakamura K; Nomoto S; Ohga S; Toriya Y; Ono M; Honda H
    Fukuoka Igaku Zasshi; 2009 Jan; 100(1):26-31. PubMed ID: 19378773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy in the management of glottic squamous cell carcinoma.
    Mendenhall WM; Strojan P; Lee AWM; Rinaldo A; Eisbruch A; Ng WT; Smee R; Ferlito A
    Head Neck; 2020 Dec; 42(12):3558-3567. PubMed ID: 32896071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan.
    Yasuda K; Uchinami Y; Kano S; Taguchi J; Kawakita D; Kitayama M; Nishioka K; Mori T; Koizumi F; Fujii Y; Shimizu Y; Kobashi K; Yoshimoto S; Nibu KI; Homma A; Aoyama H
    Int J Clin Oncol; 2024 Mar; 29(3):241-247. PubMed ID: 38155239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and Survival Trends in Glottic Carcinoma in Situ and Stage I Cancer From 1988 to 2012.
    Khaja SF; Hoffman HT; Pagedar NA
    Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):311-6. PubMed ID: 26481178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone.
    Bhateja P; Ward MC; Hunter GH; Greskovich JF; Reddy CA; Nwizu TI; Lamarre E; Burkey BB; Adelstein DJ; Koyfman SA
    Head Neck; 2016 Dec; 38(12):1832-1836. PubMed ID: 27299502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical options in radiotherapy-failed early glottic cancer.
    Santoro R; Meccariello G; Mannelli G; Bini B; Paiar F; Gallo O
    Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):777-85. PubMed ID: 23760534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival differences between organ preservation surgery and definitive radiotherapy in early supraglottic squamous cell carcinoma.
    Arshad H; Jayaprakash V; Gupta V; Cohan DM; Ambujakshan D; Rigual NR; Singh AK; Hicks WL
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):237-44. PubMed ID: 24255085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.